- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- May 25, 2024, 02:24:17 PM
- Local Time:
- June 17, 2024, 06:13:02 AM
- Last Active:
- May 25, 2024, 05:49:31 PM
Signature:
Anlotinib is a freshly designed tiny compound several receptor tyrosine kinase (RTK) chemical that was accepted to treat patients using cancer of the